Lv4
550 积分 2025-03-28 加入
Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease Among Overweight and Obese Patients With Type 2 Diabetes Mellitus
5个月前
已完结
[Clinical effect of Senling Baizhu san on patients with sarcopenia]
5个月前
已完结
Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021
5个月前
已完结
Scoparone alleviates nonalcoholic fatty liver disease by modulating the PPARα signaling pathway
8个月前
已完结
皖公网安备34019202002308
